May 3
|
Earnings Beat: CVS Health Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
|
May 2
|
Update: DOJ Sues Medicare Insurers Over Alleged Kickback Scheme
|
May 2
|
Sector Update: Health Care Stocks Higher Friday Afternoon
|
May 2
|
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
|
May 2
|
Eli Lilly’s Stock Selloff Is Overdone, Analysts Say. Here’s Why.
|
May 2
|
Eli Lilly's Zepbound Likely to Continue Uptake Despite CVS Decision, Truist Says
|
May 2
|
Justice Department Sues Big Medicare Insurers Alleging Kickbacks
|
May 2
|
Eli Lilly stock sell-off was 'overreaction': Analysts
|
May 2
|
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
|
May 2
|
Update: Eli Lilly Brushes Off CVS Decision to Drop Zepbound Coverage
|
May 2
|
Company News for May 2, 2025
|
May 2
|
3 Stocks in the S&P 500 Index Have Done the Unthinkable and Rocketed at Least 45% This Year Despite Trump's Tariffs
|
May 2
|
CVS Health Corp (CVS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
May 2
|
Q1 2025 Eli Lilly and Co Earnings Call
|
May 2
|
Q1 2025 CVS Health Corp Earnings Call
|
May 1
|
US Claims Medicare Insurers, Brokers Used Illegal Kickbacks
|
May 1
|
CVS stock reacts to full-year guidance, Novo Nordisk GLP-1 deal
|
May 1
|
Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'
|
May 1
|
3 things we've learned from healthcare earnings
|
May 1
|
Lilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s Wegovy
|